What Is NAD+?
NAD+ (Nicotinamide Adenine Dinucleotide) is a dinucleotide coenzyme present in all living cells. It exists in two forms — NAD+ (oxidized) and NADH (reduced) — and cycles between these states as it carries electrons in metabolic reactions. NAD+ is often called the "master regulator" of cellular metabolism because of its central role in energy production, cellular signaling, and DNA maintenance.
Unlike most peptides discussed on this site, NAD+ is not a peptide per se — it is a naturally occurring small molecule coenzyme. However, injectable NAD+ has become a major focus of anti-aging and longevity research, with a growing body of published human trials examining its effects on metabolism, cognition, and aging biomarkers.
Research consistently shows that NAD+ levels in human tissue decline by approximately 50% between age 20 and age 60. This decline has been mechanistically linked to reduced mitochondrial function, impaired DNA repair, and the general phenotypes associated with biological aging.
Mechanism of Action
- Electron carrier in energy metabolism: NAD+ is the primary electron acceptor in glycolysis, the citric acid cycle, and oxidative phosphorylation. By accepting electrons (becoming NADH), it drives ATP production in the mitochondria.
- Sirtuin activation (SIRT1–SIRT7): Sirtuins are NAD+-dependent deacetylase enzymes that regulate gene expression, DNA repair, mitochondrial biogenesis, and stress responses. SIRT1 and SIRT3 are strongly associated with longevity pathways. NAD+ is a required cofactor — without sufficient NAD+, sirtuins cannot function.
- PARP activation and DNA repair: Poly(ADP-ribose) polymerases (PARPs) detect and repair DNA strand breaks, consuming NAD+ as they work. High DNA damage load can rapidly deplete cellular NAD+ stores, impairing both energy production and further repair.
- CD38 regulation: CD38 is an enzyme that degrades NAD+ and is upregulated with aging and inflammation. Elevated CD38 activity is a major driver of age-related NAD+ decline.
- Circadian rhythm regulation: NAD+ levels oscillate with the circadian clock and help regulate SIRT1-mediated transcription of circadian genes. Disrupted NAD+ metabolism has been linked to circadian dysfunction and accelerated metabolic aging.
Reported Research Benefits
Cellular Energy & Mitochondrial Function
Multiple human studies have demonstrated that NAD+ precursor supplementation increases circulating NAD+ levels and improves markers of mitochondrial function. A 2019 study in Cell Metabolism showed NMN supplementation in older adults improved skeletal muscle NAD+ metabolome and insulin sensitivity.
Cognitive Function & Neuroprotection
NAD+ supports brain health through SIRT1-mediated neuroprotection, mitochondrial health in energy-intensive neurons, and PARP-1 activation for neuronal DNA repair. Early human trials suggest improvements in cognitive performance in older adults.
DNA Repair Enhancement
As a required cofactor for PARP enzymes, NAD+ availability directly influences the rate and quality of DNA repair. Restoring NAD+ levels has been shown in animal models to meaningfully improve DNA repair capacity, potentially slowing genomic instability.
Metabolic Health & Insulin Sensitivity
Clinical trials have shown that NAD+ precursor supplementation improves insulin sensitivity, reduces liver fat accumulation, and improves metabolic markers in obese and older individuals. Sirtuin-mediated deacetylation of metabolic enzymes plays a central role in these effects.
Reconstitution Protocol
Injectable NAD+ is typically supplied as a lyophilized powder. Use sterile water for injection (not BAC water) — NAD+ is sensitive to benzyl alcohol at high concentrations over extended storage. For single-use vials, sterile water is appropriate.
- Wipe the rubber stopper of the NAD+ vial and sterile water vial with alcohol swabs. Allow to air dry.
- Draw the required volume of sterile water into a syringe.
- Slowly inject sterile water along the inner wall of the NAD+ vial.
- Gently swirl until the powder fully dissolves. Solution should be clear to faintly yellow.
- For IV infusion, transfer to an IV bag. For SQ injection, load into syringes and refrigerate.
Reconstitution Reference Table
| Vial Size | Sterile Water | Concentration | 250 mg Dose | 500 mg Dose |
|---|---|---|---|---|
| 500 mg | 5 mL | 100 mg/mL | 2.5 mL | 5.0 mL |
| 500 mg | 10 mL | 50 mg/mL | 5.0 mL | 10.0 mL |
| 1,000 mg | 10 mL | 100 mg/mL | 2.5 mL | 5.0 mL |
Dosage Protocol
IV Infusion Protocol
| Protocol | Dose per Session | Infusion Rate | Frequency |
|---|---|---|---|
| Loading / Intensive | 500–1,000 mg | Slow drip over 2–4 hours | Daily for 4–10 days |
| Maintenance | 250–500 mg | Over 1–2 hours | 1–2× per week |
| Monthly Boost | 500–750 mg | Over 2–3 hours | Once monthly |
Subcutaneous Protocol
| Category | Dose | Frequency | Notes |
|---|---|---|---|
| Conservative Start | 50–100 mg | Daily | Assess tolerance; SQ may cause mild flushing |
| Standard SQ | 100–250 mg | Daily or every other day | Most practical for ongoing protocols |
| Higher Dose SQ | 250–500 mg | Every other day | Split into multiple injection sites |
Side Effects & Safety Considerations
NAD+ has one of the more established human safety profiles among injectable research compounds, with multiple clinical trials in human subjects.
- Flushing and warmth: Most commonly reported effect, particularly with rapid IV infusion. Slowing the infusion rate typically resolves this.
- Nausea: Occurs in some individuals, especially at higher IV doses.
- Chest tightness or pressure: Reported at higher infusion rates; almost always resolves with rate reduction.
- Muscle cramps: Reported during IV infusion; attributed to electrolyte shifts.
- Injection site reactions: For SQ administration, redness and mild swelling are common due to volume and osmolarity.
- Headache and fatigue: Reported in some individuals in the first 1–2 sessions, typically resolving.
Storage Guidelines
| State | Temperature | Duration | Notes |
|---|---|---|---|
| Lyophilized powder | Refrigerator (2–8°C) | Up to 24 months | Protect from light; avoid humidity |
| Reconstituted solution | Refrigerator (2–8°C) | 24–72 hours | Use promptly; NAD+ hydrolyzes in solution |
| IV bag (diluted) | Refrigerator | Use within 24 hours | Do not freeze reconstituted or diluted solutions |
Ready to Source NAD+?
Purchase NAD+ vials and a complete starter kit from our trusted research supplier. Everything you need for SQ or IV protocols.
Primary Research Sources
- Yoshino, J. et al. (2021). "Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women." Science.
- Rajman, L., Chwalek, K. & Sinclair, D.A. (2018). "Therapeutic Potential of NAD-Boosting Molecules." Cell Metabolism.
- Verdin, E. (2015). "NAD+ in aging, metabolism, and neurodegeneration." Science.
- Martens, C.R. et al. (2018). "Chronic nicotinamide riboside supplementation in healthy middle-aged and older adults." Nature Communications.
